Bookmark

Add to MyYahoo RSS

Arena Pharmaceuticals News

News on Arena Pharmaceuticals (Ticker: ARNA) continually updated from thousands of sources around the net.

Monday Aug 25 | Seeking Alpha

Belviq Sales Rise 2%

Sales of the anti-obesity pill Belviq from Arena Pharmaceuticals continued to buck the seasonality factor by bringing in a 2% increase in week over week sales according to industry tracker IMS Health.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing, Sales, TV Advertising, Startups, VIVUS

Monday Aug 25 | BioSpace

Biotech Hiring Surge: Trends To Watch; Industry Tips from Arena Pharmaceuticals, Inc.

August 25, 2014 By Josh Baxt , BioSpace.com Exclusive Story Everyone remembers the bad old days of 2009.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, BioSpace.com, Arena Pharmaceuticals

Fri Aug 15, 2014

Seeking Alpha

FDA Data: Good News For One Anti-Obesity Company, Not So Good For Another

The FDA Adverse Events raw data for Q4 of 2013 have been released, and while the exact information relating to the nature of adverse events will take some time to make its way to the public, it is possible to search through the raw data to see the number of times that a particular drug comes up within the data.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Startups, VIVUS

Wed Aug 13, 2014

Seeking Alpha

A Deeper Look At MannKind - Sanofi Deal And Valuation

The excitement of the new deal between MannKind and Sanofi has now been absorbed, and the street is now assessing how it feels the deal will impact MannKind.

Comment?

Related Topix: Biotech, MannKind, Medicine, Healthcare Industry, Arena Pharmaceuticals

AmericanBankingNews.com

Arena Pharmaceuticals Short Interest Down 2.2% in July

Shares of Arena Pharmaceuticals were the recipient of a significant decrease in short interest during the month of July.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Mon Aug 11, 2014

Seeking Alpha

For Lexicon Pharmaceuticals, No News Remains Bad News

Lexicon updates investors on its second quarter results, but still has no partner to develop LX4211 in Type 2 diabetes.

Comment?

Related Topix: Biotech, Lexicon Pharmaceuticals, Medicine, Lexicon Genetics, Healthcare Industry, Diabetes, Health, Johnson and Johnson, AstraZeneca Group

Sys-Con Media

Post-Earnings Review and Highlights - Arena Pharma

Investor-Edge.com has issued complimentary earnings coverage on Arena Pharmaceuticals Inc. as the company featured in the headlines on, per diluted share decline in net income per share in the second quarter of 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing

Fri Aug 08, 2014

Seeking Alpha

Arena's Belviq Bucks Seasonality With 3.6% Week Over Week Gain

Sales of the anti-obesity pill Belviq from Arena Pharmaceuticals continue to buck the seasonality of the weight loss sector with a 3.6% week over week gain.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Thu Aug 07, 2014

AmericanBankingNews.com

Arena Pharmaceuticals Receives Consensus Rating of "Hold" from Brokerages

Shares of Arena Pharmaceuticals have earned a consensus rating of "Hold" from the eight ratings firms that are currently covering the stock, Analyst Ratings News reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Seeking Alpha

Orexigen Hits Expectations But That Is Not The Big News

Orexigen announced its Q2 financial results this morning and the loss of $0.21 cents came in line with expectations.

Comment?

Related Topix: Biotech, Food and Drug Administration, Marketing, Sales, Startups, VIVUS, Medicine, Healthcare Industry

Mon Aug 04, 2014

Seeking Alpha

One-Time Stock Sale Boosts Arena To Profit

Arena Pharmaceuticals beat the street by an impressive $0.14 per share. Some investors were thrilled with the news, but more experienced investors saw the quarter for what it was and removed the one-time event to look at this quarter from a business perspective.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Fri Aug 01, 2014

Sys-Con Media

Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results

"Other recent notable achievements consist of advancing our internally discovered pipeline and lorcaserin life-cycle management programs, and establishing a marketing and supply agreement for BELVIQ in IMS Health estimates that approximately 110,000 prescriptions for BELVIQ were filled in the second quarter of 2014, representing growth of ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing, Sales, Israel, World News, Middle East

Thu Jul 31, 2014

Seeking Alpha

Possible Delay In Orexigen Approval Process In Europe

Orexigen announced on July 30 that the company has received a List of Outstanding Issues in the form of a 180 day Letter from the Committee for Medical Products For Human Use regarding the anti-obesity drug Contrave.

Comment?

Related Topix: Biotech, Startups, VIVUS, Medicine, Healthcare Industry

Seeking Alpha

Cramer's Lightning Round - 6 Biotech Picks

Arena Pharmaceuticals : "I'm not a fan of it. People got mad at me because of that, but the stock is down."

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Wed Jul 30, 2014

Forbes.com

Earnings Expected to Swing to Loss for Arena Pharmaceuticals

When Arena Pharmaceuticals reports its second quarter results on Friday, August 1, 2014, analysts are anticipating a drop into the red.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Financial Markets

Tue Jul 29, 2014

BioSpace

Eisai Inc. And Arena Pharmaceuticals, Inc. Announce BELVIQ??...

Award is considered one of the biomedical industry's top accolades. It recognizes outstanding achievements in improving the human condition through the development of innovative therapies.

Comment?

Related Topix: Biotech, Medicine, Eisai, Healthcare Industry, Food and Drug Administration, Diabetes, Health, Depression

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••